Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Jerry D, Slater"'
Autor:
Curtis M. Bryant, MD, MPH, Randal H. Henderson, MD, MBA, R. Charles Nichols, MD, William M. Mendenhall, MD, Bradford S. Hoppe, MD, MPH, Carlos E. Vargas, MD, Thomas B. Daniels, MD, C. Richard Choo, MD, Rahul R. Parikh, MD, Huan Giap, MD, PhD, Jerry D. Slater, MD, Neha Vapiwala, MD, William Barrett, MD, Akash Nanda, MD, PhD, Mark V. Mishra, MD, Seungtaek Choi, MD, Jay J. Liao, MD, Nancy P. Mendenhall, MD, the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 1-16 (2021)
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding
Externí odkaz:
https://doaj.org/article/871926a9f47046e99a4987b232eaa487
Autor:
Iain MacEwan, MD, Brian Chou, BS, Jeremy Moretz, MD, Lilia Loredo, MD, David Bush, MD, Jerry D. Slater, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 2, Pp 220-227 (2017)
Purpose: To investigate the long-term effects of vertebral-body-sparing proton craniospinal irradiation (CSI) on the spine of young patients with medulloblastoma. Methods and materials: Six children between the ages of 3 and 5 years with medulloblast
Externí odkaz:
https://doaj.org/article/72393c16e1ea4457aa013cfa8d0abb27
Autor:
Joseph I. Kang, Chung-Tsen Hsueh, Sasha Swenson, Jerry D. Slater, Mark E. Reeves, Alex Coffman, Patrick Q McGee, Baldev Patyal, Gayathri Nagaraj, Daniel C Sufficool, Gary Y. Yang
Publikováno v:
J Gastrointest Oncol
Background To report on our institutional experience using Proton stereotactic body radiation therapy (SBRT) for patients with liver metastases. Methods All patients with liver metastases treated with Proton SBRT between September 2012 and December 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb5dd26d201fd2ead4a7ba5e7a60f76b
https://doi.org/10.21037/jgo-20-424
https://doi.org/10.21037/jgo-20-424
Publikováno v:
Precision Radiation Oncology, Vol 5, Iss 3, Pp 202-204 (2021)
Concurrent chemoradiation is the standard of care for locally advanced cervical cancer and is commonly associated with mild to moderate toxicities. Severe late complications in multiple organ systems in patients without known patient‐ or treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1526b1a75703e1671970ec5fb1b5681f
https://doi.org/10.1002/pro6.1126
https://doi.org/10.1002/pro6.1126
Autor:
Jerry D. Slater, Lilia N. Loredo, Elena Titova, Andre Obenaus, Livio Narici, Andrew J. Wroe, Reinhard W. Schulte, Gregory A. Nelson
Publikováno v:
Life Sciences in Space Research. 26:140-148
Visual illusions from astronauts in space have been reported to be associated with the passage of high energy charged particles through visual structures (retina, optic nerve, brain). Similar effects have also been reported by patients under proton a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4099ae1e2ebf6750114fddeee0f714f3
https://doi.org/10.1016/j.lssr.2020.04.006
https://doi.org/10.1016/j.lssr.2020.04.006
Autor:
Samrat M. Sanghvi, Alex R. Coffman, Chung-Tsen Hsueh, Joseph Kang, Annie Park, Naveenraj L. Solomon, Carlos A. Garberoglio, Mark E. Reeves, Jerry D. Slater, Gary Y. Yang
Publikováno v:
Journal of gastrointestinal oncology. 13(4)
Epidermal growth factor receptor (EGFR) is overexpressed in pancreatic cancer. EGFR expression plays a potentially important role in modulation of tumor sensitivity to either chemotherapy or radiotherapy. Erlotinib is a receptor tyrosine kinase inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154f1927211ed06e48af9685088e4da2
https://pubmed.ncbi.nlm.nih.gov/36092320
https://pubmed.ncbi.nlm.nih.gov/36092320
Autor:
Jerry D. Slater, Joseph I. Kang, Jason M. Slater, B. Rodney Jabola, Kelcie Brown, Cherie Watt, David A. Bush, Roger Grove, Ivan C. Namihas
Publikováno v:
International Journal of Particle Therapy. 6:1-9
Purpose: To determine whether a hypofractionated proton therapy regimen will control early-stage disease and maintain low rates of side effects similar to results obtained using standard-fraction proton therapy at our institution. Materials and Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f78fd0563d87bfd8a7aea979e043339
https://doi.org/10.14338/ijpt-19-00057
https://doi.org/10.14338/ijpt-19-00057
Autor:
William Preston, Carol A. Davis, Jerry D. Slater, David A. Bush, Theodore S. Teichman, Sandra L. Teichman, Carlos A. Garberoglio, Roger Grove, Sharon S. Lum, Sharon Do, Shelly E. Cochran
Publikováno v:
Cancer Medicine
Background Because early‐stage breast cancer can be treated successfully by a variety of breast‐conservation approaches, long‐term quality of life (QoL) is an important consideration in assessing treatment outcomes for these patients. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26a620d9cb003f98fafc99a49e01175
http://europepmc.org/articles/PMC6308094
http://europepmc.org/articles/PMC6308094
Publikováno v:
International Journal of Particle Therapy. 4:28-36
PURPOSE: This prospective cohort evaluated patients with acoustic neuroma treated with proton irradiation at Loma Linda University Medical Center. A dose of 50.4 Gy in 28 fractions was given to improve hearing preservation while maintaining tumor con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348d2f9bdeabd61c7b24e3b4a2a6c93a
https://doi.org/10.14338/ijpt-14-00014.1
https://doi.org/10.14338/ijpt-14-00014.1
Autor:
Joseph I. Kang, Gary Y. Yang, Baldev Patyal, Chung-Tsen Hsueh, Daniel C. Sufficool, Mark E. Reeves, Andrew J. Wroe, Jerry D. Slater
Publikováno v:
Journal of Gastrointestinal Oncology. 10:112-117
BACKGROUND: A phase I trial to determine the maximum tolerated dose (MTD) of Proton stereotactic body radiation therapy (SBRT) for liver metastases in anticipation of a subsequent phase II study. METHODS: An institutional IRB approved phase I clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db9a59ab2bf558457f2f6851b658fe7
https://doi.org/10.21037/jgo.2018.08.17
https://doi.org/10.21037/jgo.2018.08.17